IFI-M · HAB Tri-Axis Balanced Series

Specimen SS-F-M3-00803 // MULTI-AXIS · IFI-M

HAB Tri-Axis Balanced Series I-PR

Capsicum chinense

Habanero

Tier IHAB Tri-Axis Balanced Series

Target Trait

1×

fold-change

Heat+Astringency+Bitter-Attenuation balanced tri-axis fold-change

Technical Specifications

SKU

SS-F-M3-00803

Genomic Edits

5

GC Content

47.1%

Construct Length

3,994 bp

Promoter System

Ubiquitin / T7

Expression System

Protoplast PEG-fusion

Host Strain

PEG-mediated

Receptor Target

TRPV1 + Polyphenol-astringency axis + TAS2R38 (suppression)

IFI Score

100

Pathway Edits

  • TRPV1 pathway primary gene cluster for heat (IFI-H) tri-axis component
  • Polyphenol-astringency axis pathway primary gene cluster for astringency (IFI-A) tri-axis component
  • TAS2R38 (suppression) pathway primary gene cluster for bitter-attenuation (IFI-B) tri-axis component
  • Tri-axis metabolic flux partitioning hub for concurrent HAB pathway operation
  • Cross-pathway regulatory circuit for balanced HAB triple-axis expression

Key Interventions

Triple-axis receptor co-activation: TRPV1, Polyphenol-astringency axis, and TAS2R38 (suppression) pathways simultaneously engineeredBalanced tri-axis expression strategy (HAB) with cross-pathway flux managementPEG-mediated co-transfection of axis constructs for rapid phenotypic screening of multi-axis combinations

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
—
IFI-B
—
IFI-K
—
IFI-C
—
IFI-P
—
IFI-A
—
IFI-F
—

Use Case

Tier I HAB triple-axis construct for advanced multi-modal sensory architecture combining heat, astringency, and bitter-attenuation axes. Suitable for ultra-premium ingredient formulation requiring certification across three simultaneous IFI receptor pathways.

License

$299 · Tier I License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?